
This introductory Special Report episode outlines how advances in staging and early detection are reshaping pediatric approaches to type 1 diabetes.

This introductory Special Report episode outlines how advances in staging and early detection are reshaping pediatric approaches to type 1 diabetes.

Experts discussed how the 3-stage model reframed type 1 diabetes as a condition that could be detected through earlier screening.

Clinicians reviewed evidence linking delayed diagnosis of type 1 diabetes to lasting neurologic and metabolic consequences.

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explored how C-peptide preservation reshaped both clinical management and economic considerations in type 1 diabetes.

A peer-to-peer discussion between Herbert Bravo, MD; and Marian Rewers, MD, PhD, examined immune-based treatments that preserved β-cell function and altered disease progression.

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explain how education and coordinated care are key to implementing early screening and treatment for type 1 diabetes.